muslimi-logo.png
Muslimi Lifestyle Expo 2024: A Call for Solidarity in the Face of Rising Islamophobia
July 30, 2024 15:08 ET | Muslimi Inc.
The Muslimi Lifestyle Expo 2024 promises an enriching experience with bustling bazaars, delicious halal food, fashion shows, and cultural immersion.
Logo.jpg
UMH PROPERTIES, INC. TO PARTICIPATE IN NAREIT’S REITWEEK: 2024 INVESTOR CONFERENCE
May 28, 2024 16:07 ET | UMH Properties, Inc.
FREEHOLD, NJ, May 28, 2024 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE:UMH) (TASE:UMH), today announced that the Company will participate in Nareit’s REITweek: 2024 Investor Conference, to be...
clarus_final_indentity.jpg
Clarus Therapeutics to Report Fourth Quarter and Full Year 2021 Financial and Operating Results
March 29, 2022 16:05 ET | Clarus Therapeutics Holdings, Inc.
NORTHBROOK, Ill., March 29, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (“Clarus”) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by...
BEI_ONC_4C_FlatLogo_Horizontal.jpg
BeiGene to Webcast an Analyst and Investor Event from the American Society of Hematology Annual Meeting
December 04, 2017 16:05 ET | BeiGene, LTD.
CAMBRIDGE, Mass., and BEIJING, China, Dec. 04, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative...
BEI_ONC_4C_FlatLogo_Horizontal.jpg
BeiGene to Participate in Baird and Morgan Stanley Global Healthcare Conferences
August 31, 2016 16:15 ET | BeiGene, LTD.
WALTHAM, Mass., Aug. 31, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company focused on developing innovative molecularly-targeted and immuno-oncology...